These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15880680

  • 1. Two ATM variants and breast cancer risk.
    Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G, KConFab Investigators.
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [Abstract] [Full Text] [Related]

  • 2. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ, Hiew M, Visvader JE, Leary J, Field M, Gaff CL, Gardner RJ, Trainor K, Cheetham G, Suthers G, Kirk J.
    Breast Cancer Res; 2004 Jun; 6(4):R401-7. PubMed ID: 15217508
    [Abstract] [Full Text] [Related]

  • 3. Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
    Ding H, Mao C, Li SM, Liu Q, Lin L, Chen Q.
    Breast Cancer Res Treat; 2011 Jan; 125(2):473-7. PubMed ID: 20544271
    [Abstract] [Full Text] [Related]

  • 4. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H, kConFab Investigators, Kirk JA.
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [Abstract] [Full Text] [Related]

  • 5. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
    Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P.
    Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
    [Abstract] [Full Text] [Related]

  • 6. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J, Dundr P, Kleibl Z, Pohlreich P.
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [Abstract] [Full Text] [Related]

  • 7. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
    Broeks A, Urbanus JH, de Knijff P, Devilee P, Nicke M, Klöpper K, Dörk T, Floore AN, van't Veer LJ.
    Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
    [Abstract] [Full Text] [Related]

  • 8. ATM variants and cancer risk in breast cancer patients from Southern Finland.
    Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomäki K, Blomqvist C, Børresen-Dale AL, Nevanlinna H.
    BMC Cancer; 2006 Aug 16; 6():209. PubMed ID: 16914028
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM, Choi JY, Park SK, Chung HW, Ahn B, Yoo KY, Han W, Noh DY, Ahn SH, Kim H, Wei Q, Kang D.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 16; 14(4):821-5. PubMed ID: 15824150
    [Abstract] [Full Text] [Related]

  • 10. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
    Tapia T, Sanchez A, Vallejos M, Alvarez C, Moraga M, Smalley S, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2008 Jan 16; 107(2):281-8. PubMed ID: 17351744
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K, Tommiska J, Syrjäkoski K, Kere J, Gatei M, Waddell N, Allinen M, Karppinen SM, Rapakko K, Kääriäinen H, Aittomäki K, Blomqvist C, Mustonen A, Holli K, Khanna KK, Kallioniemi OP, Nevanlinna H, Winqvist R.
    Carcinogenesis; 2007 May 16; 28(5):1040-5. PubMed ID: 17166884
    [Abstract] [Full Text] [Related]

  • 12. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL, Laugé A, Weber J, Champ J, Cavaciuti E, Russo A, Viovy JL, Stoppa-Lyonnet D.
    Breast Cancer Res Treat; 2010 Jan 16; 119(2):443-52. PubMed ID: 19404735
    [Abstract] [Full Text] [Related]

  • 13. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J, Gutiérrez-Enríquez S, Torres A, Bérez V, Sanjosé S, Galceran J, Izquierdo A, Menéndez JA, Gumà J, Borràs J.
    Clin Genet; 2008 May 16; 73(5):465-73. PubMed ID: 18384426
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
    Waddell N, Jonnalagadda J, Marsh A, Grist S, Jenkins M, Hobson K, Taylor M, Lindeman GJ, Tavtigian SV, Suthers G, Goldgar D, Oefner PJ, kConFab Investigators, Taylor D, Grimmond S, Khanna KK, Chenevix-Trench G.
    Genes Chromosomes Cancer; 2006 Dec 16; 45(12):1169-81. PubMed ID: 17001622
    [Abstract] [Full Text] [Related]

  • 15. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
    Lu PH, Wei MX, Si SP, Liu X, Shen W, Tao GQ, Chen MB.
    Breast Cancer Res Treat; 2011 Feb 16; 126(1):141-8. PubMed ID: 20665102
    [Abstract] [Full Text] [Related]

  • 16. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH.
    Cancer Res; 2001 Oct 15; 61(20):7608-15. PubMed ID: 11606401
    [Abstract] [Full Text] [Related]

  • 17. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J.
    Cancer Lett; 2005 Sep 28; 227(2):105-14. PubMed ID: 16112413
    [Abstract] [Full Text] [Related]

  • 18. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
    Bogdanova N, Cybulski C, Bermisheva M, Datsyuk I, Yamini P, Hillemanns P, Antonenkova NN, Khusnutdinova E, Lubinski J, Dörk T.
    Breast Cancer Res Treat; 2009 Nov 28; 118(1):207-11. PubMed ID: 18807267
    [Abstract] [Full Text] [Related]

  • 19. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B, Fachal L, Darder E, Balmaña J, Ramón Y Cajal T, Blanco I, Torres A, Lázaro C, Diez O, Alonso C, Santamariña M, Velasco A, Teulé A, Lasa A, Blanco A, Izquierdo A, Borràs J, Gutiérrez-Enríquez S, Vega A, Brunet J.
    Breast Cancer Res Treat; 2011 Jul 28; 128(2):573-9. PubMed ID: 21445571
    [Abstract] [Full Text] [Related]

  • 20. Dominant negative ATM mutations in breast cancer families.
    Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, Scott C, Pupo GM, Dörk T, Bendix R, Kirk J, Tucker K, McCredie MR, Hopper JL, Sambrook J, Mann GJ, Khanna KK.
    J Natl Cancer Inst; 2002 Feb 06; 94(3):205-15. PubMed ID: 11830610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.